It is important to remember that while semaglutide may cause palpitations in some users, it is also associated with heart benefits, such as reducing the risk of heart attacks and strokes in people with diabetes or obesity
Both are regenerative peptides, but their mechanisms differ
An evaluation of cimetidine and ranitidine in the pain relief and acute healing of duodenal ulcer disease
This is why a personalized approach is so vital
Ideal candidates typically include: Adults with a BMI of 30 or higher (classified as obese) Adults with a BMI of 27 or higher who have at least one weight-related condition, such as type 2 diabetes, hypertension, high cholesterol, PCOS, or obstructive sleep apnea Individuals who have tried diet and exercise consistently but havent achieved meaningful weight loss Patients seeking a non-surgical, medication-based alternative to bariatric procedures People with insulin resistance, prediabetes, or blood sugar management challenges Semaglutide is not recommended for patients who are pregnant, breastfeeding, or planning to conceive, as well as those with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2